药剂师对治疗药物的监测:它是否降低了成本?
Pedro Cardoso1, C Santos1, Francisco Rocha-Gonçalves1,2
1Luz Saúde, Lisbon, Portugal.
Global journal on quality and safety in healthcare
|June 19, 2023
概括
药剂师进行的治疗药物监测 (TDM) 显著降低了医疗保健成本. 这项研究发现了大量的成本回避,证明了医院TDM服务的经济价值.
科学领域:
- 药理学 药理学是指药理学的学科.
- 卫生经济学 卫生经济学
- 临床药房 临床药房
背景情况:
- 治疗药物监测 (TDM) 旨在保持最佳的血药物度.
- 在医院中,药剂师主导的TDM的经济益处的证据有限.
- 评估TDM服务的成本回避对于资源分配至关重要.
研究的目的:
- 为药剂师主导的TDM开发一个成本回避矩阵.
- 量化一年内在第三级医院实施TDM的总成本避免.
主要方法:
- 对362个与成年人抗生素TDM相关的药物干预措施的回顾性分析.
- 数据收集的重点是避免与药剂师主导的TDM干预相关的成本.
- 在第三级医院环境中实施TDM过程.
主要成果:
- 在一年的时间里,在一个医疗中心实现了416,584.58美元 (371,018) 的总成本避免.
- 该研究分析了成年患者对抗生素的TDM干预措施.
- 从药剂师领导的TDM中观察到显著的经济效益.
结论:
- 药剂师主导的TDM是医院环境中一个高度避免成本的策略.
- 与实施TDM服务相关的成本远远低于所获得的好处.
- 泰国药品管理 (TDM) 显示出明显的经济价值,支持其融入制药服务.
相关概念视频
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
Therapeutic Index
4.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.4K
Drug Concentration Versus Time Correlation
907
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
907
Drug Control Governance: Regulatory Bodies and Their Impact
195
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
195
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K


